MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A novel model of care for an integrated movement assessment program (I-MAP) targeted for patients with movement disorders

    V. Balasubramaniam (Wollongong, Australia)

    Objective: To provide an integrated hub where assessment and recommendations on medical, physical, functional, psychosocial needs are made efficiently, and care co-ordination and support services…
  • 2023 International Congress

    A 78-year-old man with progressive ataxia, palatal tremor, parkinsonism and motor neuron disease.

    P. Hoang, JR. Zuzuarregui (San Francisco, USA)

    Objective: To report a unique case of palatal tremor associated with parkinsonism, ataxia and motor neuron disease. Background: Progressive ataxia with palatal tremor (PAPT) is…
  • 2023 International Congress

    6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET striatal binding patterns in patients with Parkinson’s Disease and Parkinson Plus Syndromes.

    A. Buckland, T. Lee, R. Stell, S. Ghosh, J. Rodrigues, W. Yau, S. Vijayan, R. Francis, K. Sek, L. Morandeau, A. Jacques, T. Hagan, J. Watts, E. Campbell, N. Loh (Nedlands, Australia)

    Objective: In this study we investigate striatal binding patterns in patients with Idiopathic Parkinson’s disease (IPD), compared to those with Parkinson Plus syndromes (PPS) versus…
  • 2023 International Congress

    Olfactory dysfunction and neuropsychiatric manifestations in early drug-naïve Parkinson’s disease

    P. Julayanont (Phoenix, USA)

    Objective: To determine the severity of various neuropsychiatric disturbances in drug-naïve Parkinson’s disease (PD) patients with (PD-OD) and without olfactory dysfunction (PD-NOD) compared to healthy…
  • 2023 International Congress

    Transferrin as a possible CSF biomarker in neurodegenerative proteinopathies

    K. Mensikova, P. Kanovsky, K. Klicova, D. Konickova, S. Kurcova, M. Nevrly, P. Otruba, Z. Grambalova, M. Kaiserova, J. Zapletalova (Olomouc, Czech Republic)

    Objective: The aim of this study was to determine whether cerebrospinal fluid (CSF) levels of transferrin differ between patients with Parkinson´s disease (PD), multiple system…
  • 2023 International Congress

    Patterns of Parkinson disease mitochondrial brain function indexed by 31P magnetic resonance spectroscopy

    F. Lopez, C. Hess, A. Ray, R. O'Connell, A. O'Shea, L. Kenney, A. Ratajska, G. Alexander, A. Woods, M. Okun, D. Bowers (Gainesville, USA)

    Objective: To examine whether individuals with PD show greater temporal than frontal high energy phosphate metabolism (31P MRS ATP) that is similar or different from…
  • 2023 International Congress

    Distinct temporal and spatial alteration of immunoproteasome in Parkinson’s Disease pathogenesis

    HD. Nguyen, YE. Kim, TT. Lai, HN. Pham, IH. Kwak, H. Ma (Anyang, Gyeonggi-do, Republic of Korea)

    Objective: We aimed to investigate the temporal and spatial evolution of immunoproteasome in the central nervous system (CNS) during PD pathogenesis using mouse model. Background:…
  • 2023 International Congress

    Clinical Profile Of Drug-Induced Movement Disorders In Cipto Mangunkusumo Hospital, Indonesia

    V. Sutanto, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: We aimed to portray the clinical spectrum of Drug-induced movement disorders (DIMDs) in Cipto Mangunkusumo Hospital, Jakarta, Indonesia Background: DIMDs remain a significant burden…
  • 2023 International Congress

    Classification of Obstructive Sleep Apnea based on Statistical Features of the RR Interval using the Support Vector Machine Algorithm

    R. Fajar, E. Syafruddin, S. Putry (Sleman, Indonesia)

    Objective: In this study, we propose a method to detect Obstructive sleep apnea (OSA) based on electrocardiogram (ECG) signals based on machine learning using Support Vector…
  • 2023 International Congress

    A vicious cycle of karyopherin abnormalities in synucleinopathies

    D. Sharipov, E. Bereczki, R. Killick, T. Hortobagyi, C. Troakes, D. Aarsland, F. Hirth (London, United Kingdom)

    Objective: This study aims to investigate the role of karyopherin abnormalities in the onset and progression of synucleinopathies. Background: Despite differences in clinical manifestations, Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley